Contineum Therapeutics (CTNM) Shares Issued (2023 - 2026)

Contineum Therapeutics' Shares Issued history runs 4 years deep, the most recent figure standing at $198000.0 for Q1 2026.

• In Q1 2026, Shares Issued rose 725.0% year-over-year to $198000.0; the TTM figure through Mar 2026 stood at $118.6 million (up 210.39% YoY), while the FY2025 annual figure was $467000.0, up 15.31% from the prior year.
• Shares Issued was $198000.0 for Q1 2026 at Contineum Therapeutics, down from $99.2 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $99.2 million in Q4 2025 to a low of -$107.9 million in Q2 2024.
• Historically, Shares Issued has averaged $954250.0 across 4 years, with a median of $153500.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Issued plunged 1348650.0% in 2024, then jumped 38499.22% in 2025.
• A 4-year view of Shares Issued shows it stood at $159000.0 in 2023, then jumped by 61.64% to $257000.0 in 2024, then surged by 38499.22% to $99.2 million in 2025, then sank by 99.8% to $198000.0 in 2026.
• The last three Shares Issued figures came in at $198000.0 (Q1 2026), $99.2 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.